Vivo Bio Tech Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 135.36 million compared to INR 129.2 million a year ago. Revenue was INR 135.45 million compared to INR 129.2 million a year ago. Net income was INR 1.49 million compared to INR 13.72 million a year ago. Basic earnings per share from continuing operations was INR 0.1 compared to INR 0.97 a year ago. Diluted earnings per share from continuing operations was INR 0.1 compared to INR 0.93 a year ago.
For the nine months, sales was INR 374.72 million compared to INR 360.86 million a year ago. Revenue was INR 374.87 million compared to INR 363.37 million a year ago. Net income was INR 5.86 million compared to INR 28.89 million a year ago. Basic earnings per share from continuing operations was INR 0.4 compared to INR 2.03 a year ago. Diluted earnings per share from continuing operations was INR 0.4 compared to INR 1.95 a year ago.